These are dramatically different doses with dramatically different effects
If you suspect an adverse reaction to your GLP-1 medicine, you can report it through the MHRA Yellow Card scheme at yellowcard
In fact, a 2022 trial published in Diabetes, Obesity and Metabolism shows that, on average, people gain back two-thirds of their weight after discontinuing a GLP-1
The IRS-1 G972R Polymorphism and Type 2 Diabetes: A Paradigm for the Difficult Ascertainment of the Contribution to Disease Susceptibility of Low Frequency-Low Risk Variants. Nesti, Lorenzo, et al
Biopsies of their tongues also revealed that those taking semaglutide had greater activity of genes that may be involved in taste bud renewal and transmission of nerve signals related to taste
Eur.J Gastroenterol.Hepatol